210 related articles for article (PubMed ID: 11778099)
1. [From heparin to synthetic antithrombotic drugs].
Palareti G; Cosmi B
Minerva Anestesiol; 2001 Sep; 67(9 Suppl 1):76-81. PubMed ID: 11778099
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
Bauer KA
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):4-10. PubMed ID: 12463577
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
5. From heparins to factor Xa inhibitors and beyond.
Alban S
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():12-20. PubMed ID: 15701143
[TBL] [Abstract][Full Text] [Related]
6. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
7. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
8. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
9. Emerging anticoagulants: mechanism of action and future potential.
Klement P; Rak J
Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
[TBL] [Abstract][Full Text] [Related]
10. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
Haas S
Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
[TBL] [Abstract][Full Text] [Related]
11. New anticoagulants.
Bauer KA
Curr Opin Hematol; 2008 Sep; 15(5):509-15. PubMed ID: 18695376
[TBL] [Abstract][Full Text] [Related]
12. Pentasaccharides. The new anticoagulants.
Abdel-Razeq H
Saudi Med J; 2004 Aug; 25(8):983-90. PubMed ID: 15322584
[TBL] [Abstract][Full Text] [Related]
13. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa.
Petitou M; Duchaussoy P; Herbert JM; Duc G; El Hajji M; Branellec JF; Donat F; Necciari J; Cariou R; Bouthier J; Garrigou E
Semin Thromb Hemost; 2002 Aug; 28(4):393-402. PubMed ID: 12244487
[TBL] [Abstract][Full Text] [Related]
14. New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Morris TA
Clin Chest Med; 2010 Dec; 31(4):707-18. PubMed ID: 21047577
[TBL] [Abstract][Full Text] [Related]
15. Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery.
Comp PC
Pharmacotherapy; 2003 Jun; 23(6):772-87. PubMed ID: 12820819
[TBL] [Abstract][Full Text] [Related]
16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
17. Current concepts for the prevention of venous thromboembolism.
Bramlage P; Pittrow D; Kirch W
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():4-11. PubMed ID: 15701142
[TBL] [Abstract][Full Text] [Related]
18. [State of the art: low-molecular-weight heparin and beyond].
Cimminiello C; Casali G; Vitali L
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
[TBL] [Abstract][Full Text] [Related]
19. Oral factor Xa inhibitors for venous thromboembolism prevention in major orthopedic surgery: a review.
Imberti D; Prisco D
Pathophysiol Haemost Thromb; 2008; 36(5):217-26. PubMed ID: 19996630
[TBL] [Abstract][Full Text] [Related]
20. Heparin: from animal organ extract to designer drug.
Middeldorp S
Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
